Drug recall · November 13, 2024
Morphine Sulfate Extended-Release Tablets 30 mg recall
Why: Failed Impurities/Degradation Specification
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01.
- Lots / codes
Lot# FG13996, Exp 09/30/2025
- Quantity
- 532 100-count bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- October 22, 2024 · Voluntary: Firm initiated
- Classified
- November 4, 2024
- Reported
- November 13, 2024
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Morphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.